URGN SCHEDULE 13G/A: SEC filing
The Toronto-Dominion Bank and its subsidiary TD Securities Inc.
Filed with the SEC on · accession 0000947263-26-000091
URGN filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 13, 2026. The Toronto-Dominion Bank and its subsidiary TD Securities Inc. filed an amended Schedule 13G reporting beneficial ownership of 2,886,236 ordinary shares of UroGen Pharma Ltd., representing approximately 5.9% of the class. The stock moved -0.8% by the first close after the filing.
Summary of the filing
The Toronto-Dominion Bank and its subsidiary TD Securities Inc. filed an amended Schedule 13G reporting beneficial ownership of 2,886,236 ordinary shares of UroGen Pharma Ltd., representing approximately 5.9% of the class. The filing is a passive institutional ownership disclosure with no intent to influence control.
Key details
How URGN stock reacted
Close before
$26.39
Nov 12, 2026
First close after
-0.80%
$26.18
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for URGN, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for URGN?
Click hereFrequently asked questions
What did URGN file with the SEC on Nov 13, 2026?
URGN filed a SCHEDULE 13G/A (SEC filing). The Toronto-Dominion Bank and its subsidiary TD Securities Inc. filed an amended Schedule 13G reporting beneficial ownership of 2,886,236 ordinary shares of UroGen Pharma Ltd., representing approximately 5.9% of the class. The filing is a passive institutional ownership disclosure with no intent to influence control.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did URGN stock react to this filing?
URGN closed at $26.39 before the filing and $26.18 on Nov 13, 2026 (-0.80%).
Other URGN SEC filings
Get alerts when URGN files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days